<DOC>
<DOCNO>
EP-0003090
</DOCNO>
<TEXT>
<DATE>
19790725
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/58 C07J-71/00 C07J-17/00 A61K-31/565 C07J-1/00 C07J-33/00 C07J-43/00 A61P-29/00 <main>C07J-1/00</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
roussel uclaf fr<sep>roussel-uclaf<sep>roussel-uclaf102, route de noisy boíte postale no.993230 romainvillefr<sep>roussel-uclaf<sep>
</APPLICANT>
<INVENTOR>
deraedt roger<sep>pierdet andre<sep>torelli vesperto<sep>deraedt, roger<sep>pierdet, andre<sep>torelli, vesperto<sep>deraedt, roger23, allée jean-baptiste clémentf-93320 pavillons sous boisfr<sep>pierdet, andré10, rue charles baudelairef-93130 noisy le secfr<sep>torelli, vesperto5, rue de la conventionf-94700 maisons alfortfr<sep>deraedt, roger  <sep>pierdet, andre<sep>torelli, vesperto<sep>deraedt, roger23, allée jean-baptiste clémentf-93320 pavillons sous boisfr<sep>pierdet, andré10, rue charles baudelairef-93130 noisy le secfr<sep>torelli, vesperto5, rue de la conventionf-94700 maisons alfortfr<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to new 17α-aryl or 17α-heteroaryl steroids, their process for the preparation, their application as a medicament and the pharmaceutical compositions containing them.The compounds of the invention respond to the formula: R₁ is hydrogen or acyl from 1 to 18 carbons, R₂ an aryl or a mixture of 6 to 12 carbons, optionally substituted, or an optionally substituted heteroaryl selected from the Furyl radicals,thienyl, pyridyl and pyrimidyl, dotted lines represent a possible double bond, and or A is an oxo and b a hydrogen, or has a β-hydroxyl and b a hydrogen or halogen, or a and b form a double bond 9 (11)Compounds 1 are anti-inflammatory.
</ABSTRACT>
</TEXT>
</DOC>
